Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TACTIC-HF: Thiazide or Acetazolamide Combination Versus Intravenous Furosemide in Ambulatory Worsening Heart Failure - a Randomized Crossover Trial

NCT07593612 is registered in ClinicalTrials.gov with Lucrecia Maria Burgos as lead sponsor.

NCT NCT07593612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07593612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TACTIC-HF: Thiazide or Acetazolamide Combination Versus Intravenous Furosemide in Ambulatory Worsening Heart Failure - a Randomized Crossover Trial
Lead sponsor
Lucrecia Maria Burgos
Phase
Phase 4
Overall status
Not yet recruiting
Start date
June 15, 2026
Completion date
January 15, 2027
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure (ahf)